Search Results

What Is Your Preferred EVAR Device and Why?

By Michael J. Singh, MD, FACS, RPVI; Sharif Ellozy, MD; Mark K. Eskandari, MD, FACS; Ross Milner, MD; Ronald M. Fairman, MD; and Peter R. Nelson, MD, MS

Chief Medical Editor's Page

By Krishna J. Rocha-Singh, MD, FACC, FAHA, FSCAI, FSVM, Guest Chief Medical Editor

Renal Artery Denervation:
A Brave New Frontier

Emerging therapies for treating patients with severe, treatment-resistant hypertension.
Compiled by Krishna J. Rocha-Singh, MD, FACC, FAHA, FSCAI, FSVM

Continued Study, Debate, and Collaboration

By Andrew Holden, MBChB, FRANZCR, and Robert Bersin, MD - Guest Chief Medical Editors

Embolization: Delivering Results

By Jafar Golzarian, MD

Creating CLI Teams

The VIVA Physicians' Vascular Leaders Forum offers guidance on core competencies and quality measures for establishing multidisciplinary CLI care teams.

By John H. Rundback, MD; Tony S. Das, MD; Peter A. Schneider, MD; and Michael R. Jaff, DO; on behalf of the VLF participants

The Restenosis Conundrum

By John R. Laird, MD

What Is the Correct Endpoint?

Discerning endpoints for clinical trials in endovascular therapy for infrainguinal arterial disease.

By Michael R. Jaff, DO

Bare Nitinol Stenting of Tibial Arteries in CLI Patients

An interim look the VIVA I/XCELL trial.

By Krishna Rocha-Singh, MD, FACC, FSCAI, on behalf of VIVA Physicians, Inc.

Interim Results From the VIVA I: Xcell Trial

Bare-nitinol stenting of tibial arteries and wound-healing assessment in critical limb ischemia patients.

By Krishna Rocha-Singh, MD, FACC, on behalf of VIVA Physicians, Inc.

The VIBRANT Trial

Comparing bare-nitinol stents to stent grafts in long superficial femoral artery lesions in this unique trial.

By Gary M. Ansel, MD, FACC; Patrick J. Geraghty, MD, FACS; Mark Mewissen, MD; and Michael R. Jaff, DO

Artificial Intelligence in Neurointerventions

A comprehensive review of AI technologies utilized in diagnosis and outcome prediction for ischemic stroke, intracranial aneurysms, and brain arteriovenous malformations.

By Rajeev D. Sen, MD, and Michael R. Levitt, MD

Update on the Role of Lower Extremity Bypass in the Management of CLI

A review of indications, technical considerations, and current data for surgical bypass.

By Michael H. Parker, MD; Dayle K. Colpitts, DO; and Richard F. Neville, MD, FACS, DFSVS, RCPSG (Hon)

Early Experiences With Thoracic Branch Devices

A look at expanding endovascular solutions for complex aortic disease, highlighting next-generation thoracic branch systems, their design innovation and early clinical experience, and the evolving regulatory landscape.

With Michael D. Dake, MD; Adam W. Beck, MD, FACS; Carlos Timaran, MD; Giovanni Tinelli, MD, PhD; Simona Sica, MD; Yamume Tshomba, MD; Robert C. Lind, MD, PhD; and Jacob Budtz-Lilly, MD, PhD, FEBVS

Thoracic Aortic Trauma: Who Gets Endovascular Intervention and How to Optimize Outcomes

The management of blunt thoracic aortic injury, from mechanism of injury and history of repair to indications for endovascular intervention, TEVAR techniques, and potential complications.

By Matthew Blecha, MD; Corinne Bunn, MD; Michael Soult, MD; and Vivian Gahtan, MD